Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,272,188,413
-$228,017,584 QoQ
Shares Held
5,055,589
-26.7% QoQ
Ownership
0.286%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
#36
of 4,138 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 96%
None 4%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WELLINGTON MANAGEMENT GROUP LLP holds $41,461,553,100 across 12 Drug Manufacturers - General names. ABBV ranks #6 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
10,998,953 | $13,192,475,293 | |
| 2 | MRK |
Merck & Co., Inc.
|
86,249,283 | $11,083,032,864 | |
| 3 | JNJ |
Johnson & Johnson
|
22,588,696 | $5,736,851,118 | |
| 4 | AZN |
Astrazeneca PLC
|
28,537,243 | $5,411,232,013 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
12,699,683 | $1,604,477,945 | |
| 6 | ABBV |
AbbVie Inc.
This page
|
5,055,589 | $1,272,188,413 | |
| 7 | AMGN |
Amgen Inc
|
2,742,271 | $993,031,171 | |
| 8 | BIIB |
Biogen Inc.
|
3,117,469 | $673,560,350 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,272,188,413 | 5,055,589 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,500,205,997 | 6,897,816 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $3,410,597,796 | 14,926,683 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $2,439,714,053 | 10,536,901 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $350,910,336 | 1,890,477 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $379,729,227 | 1,812,377 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $397,452,347 | 2,236,648 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $309,481,766 | 1,567,155 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $494,420,290 | 2,882,581 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $518,089,610 | 2,845,083 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $147,899,336 | 954,374 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $62,254,014 | 417,644 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $44,389,761 | 329,472 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $52,590,823 | 329,992 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $46,936,876 | 290,433 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $41,906,668 | 312,247 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $50,395,305 | 329,037 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $44,285,857 | 273,184 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $37,943,953 | 280,236 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $28,242,522 | 261,820 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $31,905,391 | 283,251 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $22,039,975 | 203,659 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $24,609,781 | 229,676 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $24,079,015 | 274,906 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $20,421,634 | 208,002 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $17,921,561 | 235,222 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||